Kuros Strengthens Orthobiologics Patent Portfolio
Kuros Biosurgery was granted U.S. patents related to the MagnetOs product line and parathyroid hormones containing matrices for spinal fusion....
Kuros Biosurgery was granted U.S. patents related to the MagnetOs product line and parathyroid hormones containing matrices for spinal fusion....
Study results support the use of NuVasive's Attrax® Putty as a standalone bone graft substitute for autograft in instrumented thoracolumbar...
Biogennix received FDA 510(k) clearance to market Agilon™ moldable bone graft for use in posterolateral spine procedures when mixed with autograft....
DiscGenics completed enrollment in its Phase I/II first-in-human U.S. clinical study of injectable disc cell therapy to treat degenerative disc disease....
Biocomposites commenced U.S. launch of STIMULAN® Rapid Cure 3cc synthetic calcium sulfate, designed specifically for smaller voids in the foot and ankle....
Bone Solutions announced successful implantation in over 1,000 cases with magnesium-based OsteoCrete® bone void filler....
Results from clinical study of BBS-Bioactive Bone Substitutes' ARTEBONE® paste showed a fusion rate comparable with that of autograft....
Onkos Surgical is marketing GenVieâ„¢ magnesium-based bone void filler through a distribution agreement with Bone Solutions....
GreenBone Ortho received approval under the CE Mark for GreenBone Bone Substitute™....
Royal Biologics launched MAGNUS, a viable cellular bone allograft that uses a DMSO-free cryoprotectant....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.